Arcutis Biotherapeutics Announces Second Quarter 2024 Financial Results and Hosts Conference Call

WESTLAKE VILLAGE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) --

Arcutis Biotherapeutics Inc. (Nasdaq: ARQT), a biopharmaceutical company focused on developing and commercializing novel treatments for immune-mediated dermatological diseases, today announced that it will report its second quarter 2024 financial results after the close of the market on Monday, August 14, 2024.

The company will host a conference call and webcast to discuss the financial results at 4:30 p.m. ET on the same day. To access the conference call, please dial 877-407-8293 (domestic) or 201-689-8354 (international) and enter conference ID 13732937. A live webcast of the conference call will be available on the Investors section of the Arcutis website at www.arcutis.com.

A replay of the webcast will be available on the Arcutis website for 30 days following the event.